Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Metsera, Inc. - Common Stock (NQ:MTSR)

71.38 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 65,641
Open 71.38
Bid (Size) 77.00 (1,000)
Ask (Size) 77.10 (100)
Prev. Close 71.38
Today's Range 71.38 - 71.38
52wk Range 12.30 - 74.42
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novo Nordisk Snaps 11-Day Losing Streak After Court Rejects Pfizer’s Challenge To $10B Metsera Deal
Delaware Chancery Judge Morgan Zurn ruled that Pfizer’s objections did not justify delaying Novo’s $10 billion acquisition of obesity-drug startup Metsera. 
Via Stocktwits
Topics Law Enforcement
Here's Why Shares in Viking Therapeutics Shot Higher in October
Three factors took Viking's shares higher in the month. 
Via The Motley Fool

Performance

YTD
+169.4%
+169.4%
1 Month
+36.0%
+36.0%
3 Month
+113.5%
+113.5%
6 Month
+208.5%
+208.5%
1 Year
+169.4%
+169.4%

More News

Read More
Can Novo Nordisk’s ‘Attractive’ Fundamentals Outweigh Slowing Wegovy Sales And A $149 Price Cap?
Via Stocktwits
Topics Lawsuit
Novo, Pfizer Are Battling To Buy The Future Of Weight-Loss — But Viking Already Owns It
Via Benzinga
Palantir, Hertz, Metsera, Uber, DraftKings: Stocks Making The Biggest Moves Today
Via Stocktwits
Novo Nordisk Q3 Preview: Analysts See Profit Drop As Obesity Market Cools, Pfizer Tensions Rise
Via Stocktwits
The Battle For Metsera Acquisition Heats Up As Pfizer Files A Second Lawsuit
Via Stocktwits
Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera
Via Stocktwits
Pfizer, Novo Nordisk Intensify Fight For Metsera As Buyout Offers Continue To Climb
Via Benzinga
Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion
Via Investor's Business Daily
Metsera Gets Revised Bids From Pfizer, Novo Nordisk: Here’s Why It Matters
Via Stocktwits
Pfizer Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
Did Novo Nordisk Just Say "Checkmate" to Pfizer?
Via The Motley Fool
Topics Intellectual Property
Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo
Via Investor's Business Daily
Topics Economy Lawsuit
Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle
Via Benzinga
Topics Lawsuit
Meet the 7% Yield Dividend Stock That Could Soar in 2026
Via The Motley Fool
Topics Intellectual Property World Trade
Is It Time to Dump Your Shares of Pfizer?
Via The Motley Fool
Topics Intellectual Property
Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal
Via Investor's Business Daily
Topics Law Enforcement Lawsuit
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
Via Stocktwits
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera
Via Investor's Business Daily
Topics Economy Government
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Pfizer Blasts Novo Nordisk's $9 Billion Counteroffer For Metsera As 'Reckless'
Via Benzinga
The market is filled with gapping stocks in Thursday's session.
Via Chartmill
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday
Via Benzinga

Frequently Asked Questions

Is Metsera, Inc. - Common Stock publicly traded?
Yes, Metsera, Inc. - Common Stock is publicly traded.
What exchange does Metsera, Inc. - Common Stock trade on?
Metsera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Metsera, Inc. - Common Stock?
The ticker symbol for Metsera, Inc. - Common Stock is MTSR on the Nasdaq Stock Market
What is the current price of Metsera, Inc. - Common Stock?
The current price of Metsera, Inc. - Common Stock is 71.38
When was Metsera, Inc. - Common Stock last traded?
The last trade of Metsera, Inc. - Common Stock was at 11/05/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.